mounjaro tirzepatide injection 5mg solution for 5 mg 0.5 ml 4 pen Eli Lilly launches weight-loss drug
Description
Simply take one tasteless capsule twice daily before breakfast and dinner to start seeing results in as little as four weeks

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at 13 weeks for adults with overweight or obesity, according to findings from the VENTURE trial published in Obesity

Prescriptions for Ozempic, Wegovy, Zepbound, and Mounjaro sent to your pharmacy or delivered when appropriate, with insurance verification and self-pay options available

If you are preparing for surgery, one of the most important safety steps is to inform your surgeon and anesthesia team if you are taking a GLP-1 medication

GLP-1 receptor agonist
